These effects are dependent on upregulated PPAR-γ and SREBP1-mediated lipogenesis, inflammation, and cancer progression via activation of the pro-proliferative insulin receptor or insulin-like growth factor 1 receptor (IGF-1R)/Akt pathway [95]. The gene discussed is INSR; the disease is cancer.